Similarly, Camviel et al. further reported that CAR-T cells trogocytose and internalize BCMA from myeloma cells, which leads to BCMA loss in myeloma cells and reduces the therapeutic efficacy of CAR-T cells78. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.